TAOX Stock Summary and Trading Ideas (Tao Synergies | NASDAQ:TAOX)

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Tao Synergies trades on the NASDAQ stock market under the symbol TAOX.

As of August 7, 2026, TAOX stock price declined to $3.37 with 35,359 million shares trading.

TAOX has a beta of 1.37, meaning it tends to be more sensitive to market movements. TAOX has a correlation of 0.03 to the broad based SPY ETF.

TAOX has a market cap of $25.18 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that TAOX belongs to (by Net Assets): VXF, VTI, IWC, DFAS, DFMC.

TAOX has underperformed the market in the last year with a price return of -43.4% while the SPY ETF gained +23.5%. TAOX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.3% and +2.4%, respectively, while the SPY returned +6.0% and +4.6%, respectively.

TAOX support price is $3.21 and resistance is $3.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TAOX shares will trade within this expected range on the day.